Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience
JCO Precis Oncol. 2019:3:10.1200/PO.18.00351.
doi: 10.1200/PO.18.00351.
Epub 2019 Feb 15.